Copyright
©The Author(s) 2024.
World J Clin Cases. Sep 26, 2024; 12(27): 6057-6069
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6057
Published online Sep 26, 2024. doi: 10.12998/wjcc.v12.i27.6057
Parameters | Overall | P value | Ovarian cancer | P value | GI cancers | P value |
Adjusted OR | Adjusted OR | Adjusted OR | ||||
Age in yr | ||||||
≥ 55 | 0.496 | 0.157 | 0.097 | 0.114 | 0.528 | 0.293 |
< 55 | 1.000 | 1.000 | 1.000 | |||
Sex | ||||||
Female | 1.091 | 0.872 | - | 0.566 | 0.375 | |
Male | 1.000 | - | 1.000 | |||
CC score | ||||||
0 | 0.130 | 0.005a | 0.239 | 0.332 | 0.046 | 0.008 |
1 | 1.000 | 1.000 | 1.000 | |||
Pre-HIPEC chemotherapy | ||||||
Yes | 22.932 | 0.042a | - | |||
No | 1.000 | - | ||||
Platinum-response1 | ||||||
Resistant | 7.133 | 0.153 | - | |||
Sensitive | 1.000 | - |
- Citation: Chen CY, Huang TH, Lee LW, Lung J, Ou YC, Hung CH, Chuang HC, Chen MC, Wang TY. Prognostic factors of early recurrence after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Clin Cases 2024; 12(27): 6057-6069
- URL: https://www.wjgnet.com/2307-8960/full/v12/i27/6057.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i27.6057